We are live on
!
Find out more
Kiniksa Pharmaceuticals
KNSA
KNSA
96 hedge funds and large institutions have $306M invested in Kiniksa Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 30 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
38% more call options, than puts
Call options by funds: $2.44M | Put options by funds: $1.77M
20% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 30
3.41% more ownership
Funds ownership: 86.85% → 90.27% (+3.4%)
7% less funds holding
Funds holding: 103 → 96 (-7)
12% less capital invested
Capital invested by funds: $346M → $306M (-$40.3M)
35% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 20
Holders
96
Holders Change
-7
Holders Change %
-6.8%
% of All Funds
1.51%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
13
Increased
36
Reduced
30
Closed
20
Calls
$2.44M
Puts
$1.77M
Net Calls
+$667K
Net Calls Change
-$207K
Top Buyers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$6.16M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$5.3M |
| 3 |
Millennium Management
New York
|
+$4.88M |
| 4 |
LPC
Lion Point Capital
New York
|
+$4.5M |
| 5 |
Goldman Sachs
New York
|
+$3.79M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$9.51M |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$2.87M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.81M |
| 4 |
Renaissance Technologies
New York
|
-$1.53M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.05M |
